HRT Financial’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

HRT Financial’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-125,646	Closed	-$389K	–	4264
2021 Q4	$389K	Buy	125,646 +56,044	+81%	+$189K	﹤0.01%	2094
2021 Q3	$251K	Buy	69,602 +26,642	+62%	+$100K	﹤0.01%	2536
2021 Q2	$153K	Buy	42,960 +22,844	+114%	+$80.6K	﹤0.01%	2480
2021 Q1	$78K	Buy	+20,116	New	+$83.1K	﹤0.01%	2488
2020 Q2	–	Sell	-16,320	Closed	-$61K	–	1871
2020 Q1	$61K	Buy	+16,320	New	+$80.2K	﹤0.01%	633
2017 Q3	–	Sell	-17,800	Closed	-$49K	–	153
2017 Q2	$49K	Hold	17,800	–	–	0.08%	73
2017 Q1	$33K	Buy	+17,800	New	+$34.3K	0.03%	116

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

HRT Financial's BDSI Position: Q1 2022 in Review

HRT Financial sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 125,646 shares — an estimated $389K sold.

HRT Financial first reported a position in BDSI in Q1 2017 and held it in 7 quarters. The position peaked at $389K in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

HRT Financial reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
HRT Financial sold 125,646 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $389K.
HRT Financial first reported a position in BioDelivery Sciences International, Inc. in Q1 2017 and held it in 7 quarters.
HRT Financial's BioDelivery Sciences International, Inc. position peaked at $389K in Q4 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.